000			01605 a2200469 4500
005			20250516133443.0
264		0	_c20140205
008			201402s 0 0 eng d
022			_a1434-9949
024	7		_a10.1007/s10067-013-2182-x _2doi
040			_aNLM _beng _cNLM
100	1		_aMoraes, Julio C B
245	0	0	_aNT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study. _h[electronic resource]
260			_bClinical rheumatology _cJun 2013
300			_a879-83 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aBlood Sedimentation
650	0	4	_aEchocardiography
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aHumans
650	0	4	_aInflammation _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNatriuretic Peptide, Brain _xblood
650	0	4	_aPeptide Fragments _xblood
650	0	4	_aPilot Projects
650	0	4	_aRegression Analysis
650	0	4	_aRisk Factors
650	0	4	_aSpondylitis, Ankylosing _xblood
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
700	1		_aRibeiro, Ana C M
700	1		_aSaad, Carla G S
700	1		_aLianza, Alessandro C
700	1		_aSilva, Clovis A
700	1		_aBonfá, Eloísa
773	0		_tClinical rheumatology _gvol. 32 _gno. 6 _gp. 879-83
856	4	0	_uhttps://doi.org/10.1007/s10067-013-2182-x _zAvailable from publisher's website
999			_c22477758 _d22477758